peptide glp 1 Glucagon-like in health and disease The Analytical Scientist | GLP1
Description
Oral semaglutide is Novo Nordisks competing strategy
GLP-1s vary in benefit, cause side effects, and have high dropout
Li J, Liu X, Hu L, et al
Important cautions when interpreting the findings These results are promising, but while compelling the study does not show that the medication itself caused the differences
For weight management medications like Wegovy, discontinuation at least two months before a planned pregnancy is advised
